Literature DB >> 29020598

We Can Do Better - Improving Outcomes in the Midst of an Emergency.

Lindsey R Baden, Eric J Rubin, Stephen Morrissey, Jeremy J Farrar, Jeffrey M Drazen.   

Abstract

Mesh:

Year:  2017        PMID: 29020598     DOI: 10.1056/NEJMe1712330

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo.

Authors:  Carl A B Pearson; W John Edmunds; Thomas J Hladish; Rosalind M Eggo
Journal:  Int J Epidemiol       Date:  2022-02-18       Impact factor: 7.196

2.  Using research to prepare for outbreaks of severe acute respiratory infection.

Authors: 
Journal:  BMJ Glob Health       Date:  2019-02-13

3.  An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.

Authors:  Steven E Bellan; Rosalind M Eggo; Pierre-Stéphane Gsell; Adam J Kucharski; Natalie E Dean; Richard Donohue; Matt Zook; W John Edmunds; Frank Odhiambo; Ira M Longini; Marc Brisson; Barbara E Mahon; Ana Maria Henao-Restrepo
Journal:  Vaccine       Date:  2019-06-24       Impact factor: 3.641

4.  Meta-trial of awake prone positioning with nasal high flow therapy: Invitation to join a pandemic collaborative research effort.

Authors:  Jie Li; Ivan Pavlov; John G Laffey; Oriol Roca; Sara Mirza; Yonatan Perez; Bairbre McNicholas; David Cosgrave; David Vines; Elsa Tavernier; Stephan Ehrmann
Journal:  J Crit Care       Date:  2020-07-24       Impact factor: 3.425

5.  Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey.

Authors:  Javier Martínez-Sanz; José A Pérez-Molina; Santiago Moreno; Javier Zamora; Sergio Serrano-Villar
Journal:  EClinicalMedicine       Date:  2020-09-09

6.  Covid-19 - The Search for Effective Therapy.

Authors:  Lindsey R Baden; Eric J Rubin
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

7.  Data monitoring committees for clinical trials evaluating treatments of COVID-19.

Authors:  Tobias Mütze; Tim Friede
Journal:  Contemp Clin Trials       Date:  2020-09-19       Impact factor: 2.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.